GlobalData
GlobalData

shankar besta

  • Home
  • Author: shankar besta

Virtual try-on platforms gaining traction in make-up industry, says GlobalData

The growing prominence of technology in consumers’ day-to-day activities is enabling cosmetics manufacturers across the world to develop technology-based initiatives capable of enhancing the purchasing experience of consumers. One such concept that is gaining popularity in the make-up sector is virtual try-on (VTO). VTO uses artificial intelligence (AI) and augmented reality (AR) to deliver a […]
Read more

Singapore gets ready for bean-less coffee as brands tap into sustainability and affordability, says GlobalData

Consumers are embracing environmental responsibility through their purchase decisions by looking for products with improved sustainability and ethical production processes, as affirmed by 33% of Singaporeans*. Brands are, therefore, tapping into this trend by providing consumers with more sustainable options in coffee offerings, says  GlobalData, a leading data and analytics company. Meenakshi Haran, Consumer Lead […]
Read more

Biomarkers becoming important for approval of amyotrophic lateral sclerosis therapies, says GlobalData

The recently concluded AD/PD 2024 International Conference on Alzheimer’s Disease (AD) and Parkinson’s Disease (PD) focused on innovative approaches poised to revolutionize the treatment of amyotrophic lateral sclerosis (ALS) and the use of neurochemical biomarkers in ALS drug development. As biomarkers are used for early diagnostics in clinics and as outcome parameters for novel treatment […]
Read more

Alabama faces staggering economic costs of $7.2 billion due to obesity, reveals GlobalData

Obesity and overweight are estimated to have caused a staggering $7.2 billion reduction in Alabama’s economy in 2022, equivalent to 2.6% of the state’s gross domestic product, according to a report released by GlobalData Plc, a leading data and analytics company. GlobalData’s report, ‘Obesity’s Impact on Alabama’s Economy and Labor Force,’ analyzes the economic and […]
Read more

Medtronic’s exit from ventilator business highlights evolving industry trends, says GlobalData

In response to changing market conditions, Medtronic made a strategic decision to leave the ventilator market and reorganize its respiratory and patient monitoring businesses. The rationale behind this decision emphasizes the company’s commitment to optimizing its portfolio to align with evolving industry trends, says GlobalData, a leading data and analytics company. Medtronic’s existing ventilator portfolio […]
Read more

Philips and SyntheticMR’s collaboration pivotal in integration of AI in MRI diagnostic imaging, says GlobalData

Philips recently announced a collaboration with SyntheticMR to develop quantitative brain imaging tools powered by artificial intelligence (AI) to diagnose disorders such as multiple sclerosis (MS), traumatic brain injury, and dementia. With the growing demand for early disease diagnosis and a transformative shift towards accuracy and efficiency in diagnostic imaging, Philips and SyntheticMR’s collaboration represents […]
Read more

Transmission pipelines to lead upcoming midstream project starts in US during 2024-2028, reveals GlobalData

The trunk/transmission pipelines segment is set to dominate upcoming oil and gas midstream projects in the US by 2028, accounting for about 47% of the midstream projects starting between 2024 and 2028, says GlobalData, a leading data and analytics company. GlobalData’s latest report, “North America Oil and Gas Projects by Development Stage, Capacity, Capex, Contractor […]
Read more

Opdivo to face direct competition with Keytruda and Padcev combination in bladder cancer space, says GlobalData

Bristol Myers Squibb’s Opdivo was recently granted FDA approval in combination with cisplatin and gemcitabine as a first-line treatment for metastatic urothelial carcinoma (mUC). With this approval, Opdivo positions itself to compete with Merck & Co’s immune checkpoint inhibitor (ICI) Keytruda in combination with Astellas and Pfizer’s Padcev, a nectin-4-directed antibody-drug conjugate (ADC). The Keytruda/Padcev […]
Read more
1 83 84 85 86 87 136